Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dapagliflozin Tablets

Approval Number

国药准字H20249660

Company浙江华海药业股份有限公司

Registration Date

December 1, 2024

Drug Information

Generic Name

达格列净片

Dosage Form

片剂

Strength

10mg (以C₂₁H₂₅ClO₆计)

Drug Type

化学药品

Registration Date

December 1, 2024

Company Information

Applicant Company

Company Name浙江华海药业股份有限公司

Company Address

浙江省临海市汛桥

Manufacturing Company

Company Name浙江华海药业股份有限公司

Company Address

浙江省临海市汛桥

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy